目的:分析应用连续性血液净化治疗急性肾功能衰竭的临床疗效从而降低死亡率。方法:在我院2013年1月~2014年1月间住院治疗并符合研究条件的急性肾衰竭患者共有32例,将其作为研究对象,按照统计学原则,随机平均分为2组。对两组分别采取常规血液透析治疗和连续性血液净化治疗。其中常规血液透析治疗为对照组,连续性血液净化治疗为观察组,采用瑞典金宝及美国费森尤斯床旁持续血液净化机,对两组的临床治疗结果进行分析探讨。结果:观察组患者死亡1人,死亡率为6.25%;对照组死亡4人,死亡率为25%。可看出观察组明显低于对照组,根据统计学计算可知P<0.05,具有统计学意义。治疗后根据两组患者血肌酐(Scr)和尿素氮(BUN)的统计学计算分析可知,两组患者在治疗后相对治疗前均有明显的改善,而且观察组更为明显的优于对照组,P<0.05,具有统计学意义。结论:应用连续性血液净化治疗急性肾衰竭的临床疗效更为显著,在挽救患者的生命与促进患者肾功能恢复方面有着更为显著的作用,值得临床推广。 Objective: To analyze the clinical efficacy of continuous blood purification in the treatment of acute renal failure and thus reduce the mortality rate. Methods: A total of 32 acute renal failure patients were hospitalized in our hospital from January 2013 to January 2014 and were eligible for the study. A total of 32 acute renal failure patients were included in this study. The patients were randomly divided into two groups according to statistical principles. The two groups were taken conventional hemodialysis and continuous blood purification treatment. The conventional hemodialysis treatment for the control group, continuous blood purification treatment for the observation group, the use of Sweden Campbell and the United States Fresenius continuous bedside blood purification machine, the two groups of clinical treatment results were analyzed. Results: One patient died in the observation group with a mortality rate of 6.25%. Four people died in the control group with a mortality rate of 25%. Can be seen in the observation group was significantly lower than the control group, according to statistical calculations can be found P <0.05, with statistical significance. After treatment, according to the statistical calculation and analysis of serum creatinine (Scr) and blood urea nitrogen (BUN) in the two groups, the two groups showed a significant improvement before treatment and the observation group was more obvious than the control group , P <0.05, with statistical significance. Conclusion: The clinical curative effect of using continuous blood purification to treat acute renal failure is more significant. It has a more significant effect in saving the life of patients and promoting the recovery of renal function in patients. It is worthy of clinical promotion.